Michel Streuli

USPTO Granted Patents = 12 (Patent Applications = 1)

EPO Patents = 1

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 42(Granted Patents)

Location History:

Somerville, MA (US) (1992 - 1994)
Brookline, MA (US) (1994 - 2015)
Atherton, CA (US) (2018 - 2023)

Company Filing History:

6 out of 1,206

Dana-farber-cancer Institute Inc.

Pionyr Immunotherapeutics, Inc.

patents

Years Active: 1992-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11572407 - Anti-MARCO antibodies and uses thereof (2023-02-07),

2. 11505602 - Anti-TREM2 antibodies and related methods (2022-11-22),

3. 10508148 - Anti-TREM2 antibodies and related methods (2019-12-17),

4. RE47123 - EPHA2 receptor antagonist antibodies (2018-11-12),

5. 8992912 - Methods of use for antibodies that specifically bind to the EphA2 receptor (2015-03-31),

6. 8460667 - EPHA2 receptor antagonist antibodies (2013-06-11),

7. 6180849 - Trangenic mice with a disruption in the tiar gene (2001-01-30),

8. 5994070 - Trio molecules and uses related thereto (1999-11-30),

9. 5837811 - Proteins active in lymphocyte-mediated cytotoxicity (1998-11-17),

10. 5340935 - DNAS encoding proteins active in lymphocyte-medicated cytotoxicity (1994-08-23),

11. 5298407 - DNA encoding a protein active in lymphocyte-mediated cytotoxicity (1994-03-29),

12. 5079343 - Intracellular antigen found in subpopulation of CD8.sup.+ T lymphocytes (1992-01-07),

Title: Michel Streuli: Innovator in Antibody Research

Introduction

Michel Streuli is a prominent inventor based in Brookline, MA, known for his significant contributions to the field of antibody research. With a total of 12 patents to his name, he has made remarkable advancements in the development of therapeutic antibodies.

Latest Patents

Streuli's latest patents include innovative work on anti-MARCO antibodies and anti-TREM2 antibodies. The anti-MARCO antibodies patent provides methods for generating and utilizing these antibodies, which are crucial for various medical applications. Additionally, his anti-TREM2 antibodies patent outlines methods for enhancing immune responses and treating immune-related conditions, such as cancer, by targeting non-stimulatory myeloid cells.

Career Highlights

Throughout his career, Michel Streuli has worked with esteemed organizations, including the Dana-Farber Cancer Institute and Sanofi. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Paul J. Anderson and Stuart F. Schlossman. Their collaborative efforts have further advanced the research and development of antibody therapies.

Conclusion

Michel Streuli's innovative work in antibody research has led to significant advancements in medical science. His contributions continue to impact the field and pave the way for future discoveries.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.